1309833-21-3Relevant articles and documents
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
-
Paragraph 00207, (2017/05/02)
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
PROTEIN KINASE C INHIBITORS AND USES THEREOF
-
Page/Page column 46, (2011/06/23)
This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.